Correlation Between Virax Biolabs and Tempest Therapeutics

Can any of the company-specific risk be diversified away by investing in both Virax Biolabs and Tempest Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Virax Biolabs and Tempest Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Virax Biolabs Group and Tempest Therapeutics, you can compare the effects of market volatilities on Virax Biolabs and Tempest Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Virax Biolabs with a short position of Tempest Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Virax Biolabs and Tempest Therapeutics.

Diversification Opportunities for Virax Biolabs and Tempest Therapeutics

0.27

Correlation Coefficient

Virax Biolabs  Tempest Therapeutics

Modest diversification

The 3 months correlation between Virax and Tempest is 0.27. Overlapping area represents the amount of risk that can be diversified away by holding Virax Biolabs Group and Tempest Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tempest Therapeutics and Virax Biolabs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Virax Biolabs Group are associated (or correlated) with Tempest Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tempest Therapeutics has no effect on the direction of Virax Biolabs i.e., Virax Biolabs and Tempest Therapeutics go up and down completely randomly.

Pair Corralation between Virax Biolabs and Tempest Therapeutics

Given the investment horizon of 90 days Virax Biolabs is expected to generate 6.31 times less return on investment than Tempest Therapeutics. But when comparing it to its historical volatility, Virax Biolabs Group is 3.86 times less risky than Tempest Therapeutics. It trades about 0.02 of its potential returns per unit of risk. Tempest Therapeutics is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  163.00  in Tempest Therapeutics on November 21, 2024 and sell it today you would lose (71.00) from holding Tempest Therapeutics or give up 43.56% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Virax Biolabs Group  vs.  Tempest Therapeutics

Virax Biolabs Group

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Virax Biolabs Group are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Virax Biolabs showed solid returns over the last few months and may actually be approaching a breakup point.

Tempest Therapeutics

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Tempest Therapeutics are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Tempest Therapeutics may actually be approaching a critical reversion point that can send shares even higher in March 2025.

Pair Trading with Virax Biolabs and Tempest Therapeutics

The main advantage of trading using opposite Virax Biolabs and Tempest Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Virax Biolabs position performs unexpectedly, Tempest Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tempest Therapeutics will offset losses from the drop in Tempest Therapeutics' long position.

The idea behind Virax Biolabs Group and Tempest Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.